Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lu Gaohua, Xiusheng Miao & Liu Dou. (2021) Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity. Expert Opinion on Drug Metabolism & Toxicology 17:9, pages 1103-1124.
Read now
Read now
Articles from other publishers (15)
Slobodan P. Rendić, Rachel D. Crouch & F. Peter Guengerich. (2022) Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. Archives of Toxicology 96:8, pages 2145-2246.
Crossref
Crossref
Alena Shalimova, Viktoria Babasieva, Vladimir N Chubarev, Vadim V Tarasov, Helgi B Schiöth & Jessica Mwinyi. (2021) Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics. Pharmacogenomics 22:8.
Crossref
Crossref
Tobias Kanacher, Andreas Lindauer, Enrica Mezzalana, Ingrid Michon, Celine Veau, Jose David Gómez Mantilla, Valerie Nock & Angèle Fleury. (2020) A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine. Pharmaceutics 12:12, pages 1191.
Crossref
Crossref
Maciej Gawlik, Jakub Trawiński & Robert Skibiński. (2018) Imitation of phase I metabolism reactions of MAO-A inhibitors by titanium dioxide photocatalysis. European Journal of Pharmaceutical Sciences 114, pages 391-400.
Crossref
Crossref
Barry C. Jones, Abhishek Srivastava, Nicola Colclough, Joanne Wilson, Venkatesh Pilla Reddy, Sara Amberntsson & Danxi Li. (2017) An Investigation into the Prediction of In Vivo Clearance for a Range of Flavin-containing Monooxygenase Substrates. Drug Metabolism and Disposition 45:10, pages 1060-1067.
Crossref
Crossref
Michael Gerisch, Thomas Schwarz, Dieter Lang, Gabriele Rohde, Stefanie Reif, Isabelle Genvresse, Susanne Reschke, Dorina van der Mey & Camille Granvil. (2017) Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers. Cancer Chemotherapy and Pharmacology 80:3, pages 535-544.
Crossref
Crossref
Nikolay T. Tzvetkov, Sonja Hinz, Petra Küppers, Marcus Gastreich & Christa E. Müller. (2014) Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency. Journal of Medicinal Chemistry 57:15, pages 6679-6703.
Crossref
Crossref
Pierre Baumann & Christoph Hiemke. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
301
329
.
Steven P. Hanlon, Andrea Camattari, Sandra Abad, Anton Glieder, Matthias Kittelmann, Stephan Lütz, Beat Wirz & Margit Winkler. (2012) Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale. Chemical Communications 48:48, pages 6001.
Crossref
Crossref
Anita Rakic Ignjatovic, Branislava Miljkovic, Dejan Todorovic, Ivana Timotijevic & Milena Pokrajac. (2009)
Moclobemide monotherapy
vs.
combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study
. British Journal of Clinical Pharmacology 67:2, pages 199-208.
Crossref
Crossref
Alina Plenis, Aleksandra Chmielewska, Lucyna Konieczna & Henryk Lamparczyk. (2007) A validated high-performance liquid chromatographic method for the determination of moclobemide and its two metabolites in human plasma and application to pharmacokinetic studies. Biomedical Chromatography 21:9, pages 958-966.
Crossref
Crossref
D.F V. Lewis, B.G. Lake & M. Dickins. (2004) Substrates of Human Cytochromes P4S0 from Families CYP1 and CYP2: Analysis of Enzyme Selectivity and Metabolism. Drug Metabolism and Drug Interactions 20:3.
Crossref
Crossref
Dieter Lang & Amit Kalgutkar. 2003. Drug Metabolizing Enzymes. Drug Metabolizing Enzymes
483
539
.
Michael A. Wynalda, J. Matthew Hutzler, Michael D. Koets, Terry Podoll & Larry C. Wienkers. (2003) IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMES. Drug Metabolism and Disposition 31:7, pages 878-887.
Crossref
Crossref
D.F.V. Lewis, M. Dickins, B.G. Lake & P.S. Goldfarb. (2003) Investigation of Enzyme Selectivity in the Human CYP2C Subfamily: Homology Modelling of CYP2C8, CYP2C9 and CYP2C19 from the CYP2C5 Crystallographic Template. Drug Metabolism and Drug Interactions 19:4.
Crossref
Crossref